Aquatic Veterinary Market Report 2026

The aquatic veterinary market size has grown steadily in recent years. It will grow from $1.56 billion in 2025 to $1.63 billion in 2026 at a compound annual growth rate (CAGR) of 4.7%. The growth in the historic period can be attributed to expansion of commercial aquaculture operations, increasing disease outbreaks in aquatic species, growth in fish and shrimp farming, rising awareness of aquatic animal health, availability of basic aquatic veterinary treatments.

The aquatic veterinary market size is expected to see steady growth in the next few years. It will grow to $1.94 billion in 2030 at a compound annual growth rate (CAGR) of 4.4%. The growth in the forecast period can be attributed to increasing demand for sustainable aquaculture practices, rising investments in aquatic disease prevention, expansion of advanced diagnostic adoption, growing focus on antibiotic alternatives, increasing regulatory oversight on aquatic animal health. Major trends in the forecast period include increasing adoption of molecular diagnostic tools, rising use of probiotics and nutraceutical treatments, growing focus on preventive aquatic health management, expansion of vaccine-based disease control, enhanced monitoring of aquatic environmental conditions.

The growth of the aquaculture industry is anticipated to drive the expansion of the aquatic veterinary market in the coming years. The aquaculture industry involves the farming and cultivation of aquatic organisms, including fish, shellfish, algae, and other marine and freshwater species. This industry is expanding due to rising global demand for seafood, efforts to reduce pressure on wild fish populations, and the objective of strengthening food security. Aquatic veterinary services play a vital role in supporting aquaculture by ensuring the health of farmed species, managing and preventing diseases, and improving aquaculture farming practices. For example, in September 2023, according to the Sea Fish Industry Authority, a UK-based non-departmental public body that supports the seafood sector, aquaculture production is projected to increase to 106 million tons by 2030, reflecting a total growth of 22 percent, or approximately 19 million tons. Therefore, the expansion of the aquaculture industry is contributing to the growth of the aquatic veterinary market.

Key companies operating in the aquatic veterinary market are developing digital solutions, such as internet-based training resource modules, to enhance care quality and improve the efficiency of veterinary practices. Training resource modules are structured educational components designed to deliver organized instruction and learning materials focused on specific skills or subject areas. These modules are commonly delivered through online or offline formats to support effective training and professional development. For instance, in November 2023, Merck Animal Health, a US-based pharmaceutical company, introduced AQUA CARE365, an online educational and training platform that provides veterinary professionals with access to interactive modules, expert guidance, and practical resources. This initiative aims to strengthen knowledge and skills in aquatic animal care, ultimately improving veterinary practice standards and patient outcomes.

In July 2024, MSD Animal Health, a US-based bioscience company, acquired an aquatic business portfolio from Elanco Animal Health Incorporated for an undisclosed amount. This acquisition represents a strategic move by MSD Animal Health to broaden its presence and product offerings within the aquaculture sector, supporting its objective of advancing animal health and welfare worldwide. Elanco Animal Health Incorporated is a US-based provider of aquatic veterinary care.

Major companies operating in the aquatic veterinary market are Thermo Fisher Scientific Inc., Merck KGaA, Zoetis Inc., IDEXX BioAnalytics, Alltech Inc., Phibro Animal Health Corporation, AquaGen, AquaBioTech Group, Aquasol Corporation, Aquatic Animal Health Laboratory AAHL, Aquatic Diagnostic Services International ADSI, Aquatic Veterinary Services, Benchmark Genetics, BioMar Group, Cargill Aqua Nutrition, Skretting Group, Novus International, Pentair Aquatic Eco-Systems, Lallemand Animal Nutrition, Groupe Grimaud.

North America was the largest region in the aquatic veterinary market in 2025. The regions covered in the aquatic veterinary market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the aquatic veterinary market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the aquatic veterinary market by increasing costs of imported diagnostic kits, laboratory reagents, vaccines, and specialized pharmaceutical ingredients used in aquatic disease management. Aquaculture-intensive regions in Asia-Pacific and Latin America are most affected due to dependence on imported veterinary supplies, while Europe faces higher costs for advanced diagnostics and genetic testing tools. These tariffs are raising treatment costs for fish farms and delaying technology adoption. However, they are also encouraging regional production of veterinary biologics, local diagnostic development, and strengthened domestic supply chains for aquatic healthcare solutions.

The aquatic veterinary market research report is one of a series of new reports that provides aquatic veterinary market statistics, including aquatic veterinary industry global market size, regional shares, competitors with a aquatic veterinary market share, detailed aquatic veterinary market segments, market trends and opportunities, and any further data you may need to thrive in the aquatic veterinary industry. This aquatic veterinary market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Aquatic veterinary is a specialized branch of veterinary medicine that focuses on the healthcare, diagnosis, treatment, and prevention of diseases in aquatic animals, including fish, crustaceans, and mollusks. This discipline addresses a range of health challenges unique to aquatic species, such as infections, parasitic infestations, and environmental stressors.

The primary type within aquatic veterinary is diagnostics and treatments. Diagnostics and treatments encompass the tools and methodologies used to detect, manage, and control diseases and health conditions affecting aquatic animals. The species covered include fish, crustaceans, mollusks, and others, while disease sources include bacteria, viruses, parasites, and others. The routes of administration include water medication, medicated feed, and others, and the distribution channels comprise distributors, online stores, retail outlets, and others.

The aquatic veterinary market consists of revenues earned by entities by providing services such as training and education, veterinary research and development, aquaculture management consulting, water quality management, and emergency care services. The market value includes the value of related goods sold by the service provider or included within the service offering. The aquatic veterinary market also includes sales of medications and drugs, diagnostic kits, medical devices, and water treatment products. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.